DE3688333T2 - Antikörper gegen Polypeptide, die gegen Peptide oder Proteine mit mindestens teilweise bekannter Aminosäure oder kodierender Nukleotidsequenz komplementär sind und diesbezügliches Aufbauverfahren. - Google Patents
Antikörper gegen Polypeptide, die gegen Peptide oder Proteine mit mindestens teilweise bekannter Aminosäure oder kodierender Nukleotidsequenz komplementär sind und diesbezügliches Aufbauverfahren.Info
- Publication number
- DE3688333T2 DE3688333T2 DE89106162T DE3688333T DE3688333T2 DE 3688333 T2 DE3688333 T2 DE 3688333T2 DE 89106162 T DE89106162 T DE 89106162T DE 3688333 T DE3688333 T DE 3688333T DE 3688333 T2 DE3688333 T2 DE 3688333T2
- Authority
- DE
- Germany
- Prior art keywords
- complementary
- peptides
- proteins
- amino acid
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/708,001 US4863857A (en) | 1985-03-01 | 1985-03-01 | Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known |
US06/829,709 US5077195A (en) | 1985-03-01 | 1986-02-19 | Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3688333D1 DE3688333D1 (de) | 1993-05-27 |
DE3688333T2 true DE3688333T2 (de) | 1993-10-28 |
Family
ID=27108003
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE89106162T Expired - Fee Related DE3688333T2 (de) | 1985-03-01 | 1986-02-24 | Antikörper gegen Polypeptide, die gegen Peptide oder Proteine mit mindestens teilweise bekannter Aminosäure oder kodierender Nukleotidsequenz komplementär sind und diesbezügliches Aufbauverfahren. |
DE8686901662T Expired - Fee Related DE3679017D1 (de) | 1985-03-01 | 1986-02-24 | Komplementaere polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure- oder nukleotidkodierender sequenz und diesbezuegliches aufbauverfahren. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8686901662T Expired - Fee Related DE3679017D1 (de) | 1985-03-01 | 1986-02-24 | Komplementaere polypeptide gegen peptide oder proteine mit mindestens teilweise bekannter aminosaeure- oder nukleotidkodierender sequenz und diesbezuegliches aufbauverfahren. |
Country Status (18)
Country | Link |
---|---|
US (2) | US5077195A (de) |
EP (2) | EP0214232B1 (de) |
JP (1) | JPH07215999A (de) |
KR (1) | KR920002315B1 (de) |
AT (2) | ATE63138T1 (de) |
AU (1) | AU592781B2 (de) |
BR (1) | BR8606615A (de) |
CA (1) | CA1339606C (de) |
DE (2) | DE3688333T2 (de) |
DK (1) | DK521386A (de) |
ES (3) | ES8705919A1 (de) |
FI (1) | FI90255C (de) |
GR (1) | GR860576B (de) |
IE (1) | IE58837B1 (de) |
IL (1) | IL96043A0 (de) |
NO (1) | NO174971C (de) |
PT (1) | PT82132B (de) |
WO (1) | WO1986005208A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19805334A1 (de) * | 1998-02-11 | 1999-08-12 | Otogene Biotechnologische Fors | Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3587549T2 (de) * | 1984-10-29 | 1994-02-17 | Microgenics Corp | Ergänzungstestverfahren von proteine bindenden enzymen. |
DE3527568A1 (de) * | 1985-08-01 | 1987-02-05 | Bissendorf Peptide Gmbh | Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben |
CA1297003C (en) * | 1985-09-20 | 1992-03-10 | Jack H. Nunberg | Composition and method for treating animals |
WO1987005029A2 (en) * | 1986-02-19 | 1987-08-27 | Triton Biosciences Inc | Peptides affecting blood pressure regulation |
US4772684A (en) * | 1987-01-20 | 1988-09-20 | Triton Biosciences, Inc. | Peptides affecting blood pressure regulation |
JPH02104595A (ja) * | 1988-03-04 | 1990-04-17 | Univ Alabama | 非ペプチドのペプチド相当物及びそのデザイン方法 |
DE69033395D1 (de) * | 1989-07-31 | 2000-01-20 | Tecnogen Scpa | Verfahren zur Identifizierung und Herstellung von Bindungsstellen aufeinanderwirkender Proteine |
US5324512A (en) * | 1990-12-26 | 1994-06-28 | The Population Council | [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses |
JPH05262788A (ja) * | 1991-09-03 | 1993-10-12 | Hitachi Chem Co Ltd | ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法 |
US6017512A (en) * | 1992-06-23 | 2000-01-25 | Diatide, Inc. | Radiolabeled peptides |
US5620675A (en) | 1992-06-23 | 1997-04-15 | Diatech, Inc. | Radioactive peptides |
EP0672421B1 (de) * | 1993-10-07 | 2002-03-20 | Kurashiki Boseki Kabushiki Kaisha | Hemmer der aktivität von endothelin |
US6051206A (en) * | 1994-06-03 | 2000-04-18 | Diatide, Inc | Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
IL115177A0 (en) * | 1994-09-16 | 1995-12-31 | Immunomedics Inc | Phosphorus-32 labeling of antibodies for cancer therapy |
US5523208A (en) * | 1994-11-30 | 1996-06-04 | The Board Of Trustees Of The University Of Kentucky | Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks |
JP3737516B2 (ja) * | 1995-06-26 | 2006-01-18 | パーセプティブ バイオシステムズ,インコーポレーテッド | 高速自動化連続流、多次元分子選別および分析 |
US5807552A (en) * | 1995-08-04 | 1998-09-15 | Board Of Regents, The University Of Texas System | Compositions for conferring immunogenicity to a substance and uses thereof |
WO1999027964A1 (en) * | 1997-12-01 | 1999-06-10 | Cfy Biomedicals, Inc. | Multivalent recombinant antibodies for treating hrv infections |
WO1999055911A1 (en) * | 1998-04-24 | 1999-11-04 | Fang Fang | Identifying peptide ligands of target proteins with target complementary library technology (tclt) |
US20030035798A1 (en) * | 2000-08-16 | 2003-02-20 | Fang Fang | Humanized antibodies |
ES2316356T3 (es) * | 1999-03-09 | 2009-04-16 | Fornix Biosciences N.V. | Peptidos sinteticos complementarios y sus utilizaciones oftalmologicas. |
GB2356401A (en) * | 1999-11-19 | 2001-05-23 | Proteom Ltd | Method for manipulating protein or DNA sequence data |
GB9929466D0 (en) * | 1999-12-13 | 2000-02-09 | Proteom Ltd | Complementary peptide ligands generated from microbial genome sequences |
GB9929469D0 (en) * | 1999-12-13 | 2000-02-09 | Proteom Ltd | Complementary peptide ligands generated from plant genomes |
GB9929464D0 (en) * | 1999-12-13 | 2000-02-09 | Proteom Ltd | Complementary peptide ligande generated from the human genome |
AU2001294822A1 (en) * | 2000-09-26 | 2002-04-08 | Geneformatics, Inc. | Methods for determining aproximations of three dimensional polypeptide structure |
GB0025251D0 (en) * | 2000-10-14 | 2000-11-29 | Proteom Ltd | Antisense peptides to Fc receptors and their uses |
EP2365062B1 (de) * | 2001-02-20 | 2016-11-23 | University Of Georgia Research Foundation, Inc. | Schnelle Herstellung monoklonaler Antikörper |
WO2003062370A2 (en) | 2001-07-19 | 2003-07-31 | Perlan Therapeutics, Inc. | Multimeric proteins and methods of making and using same |
WO2008157236A1 (en) * | 2007-06-14 | 2008-12-24 | The Board Of Regents For Oklahoma State University | Vaccines containing canine parvovirus genetic variants |
US8227583B2 (en) * | 2007-06-14 | 2012-07-24 | The Board Of Regents For Oklahoma State University | Vaccines containing canine parvovirus genetic variants |
US20190062373A1 (en) * | 2017-08-30 | 2019-02-28 | Peption, LLC | Method of generating interacting peptides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6936694B1 (en) * | 1982-05-06 | 2005-08-30 | Intermune, Inc. | Manufacture and expression of large structural genes |
-
1986
- 1986-02-19 US US06/829,709 patent/US5077195A/en not_active Expired - Fee Related
- 1986-02-24 DE DE89106162T patent/DE3688333T2/de not_active Expired - Fee Related
- 1986-02-24 AT AT86901662T patent/ATE63138T1/de not_active IP Right Cessation
- 1986-02-24 AT AT89106162T patent/ATE88572T1/de not_active IP Right Cessation
- 1986-02-24 BR BR8606615A patent/BR8606615A/pt unknown
- 1986-02-24 DE DE8686901662T patent/DE3679017D1/de not_active Expired - Fee Related
- 1986-02-24 WO PCT/US1986/000353 patent/WO1986005208A1/en active IP Right Grant
- 1986-02-24 AU AU55102/86A patent/AU592781B2/en not_active Ceased
- 1986-02-24 EP EP86901662A patent/EP0214232B1/de not_active Expired - Lifetime
- 1986-02-24 EP EP89106162A patent/EP0332225B1/de not_active Expired - Lifetime
- 1986-02-24 KR KR1019860700762A patent/KR920002315B1/ko not_active IP Right Cessation
- 1986-02-26 CA CA000502748A patent/CA1339606C/en not_active Expired - Fee Related
- 1986-02-27 IE IE52786A patent/IE58837B1/en not_active IP Right Cessation
- 1986-02-28 GR GR860576A patent/GR860576B/el unknown
- 1986-02-28 ES ES552534A patent/ES8705919A1/es not_active Expired
- 1986-03-03 PT PT82132A patent/PT82132B/pt not_active IP Right Cessation
- 1986-10-30 FI FI864427A patent/FI90255C/fi not_active IP Right Cessation
- 1986-10-31 DK DK521386A patent/DK521386A/da not_active Application Discontinuation
- 1986-10-31 NO NO864369A patent/NO174971C/no unknown
- 1986-11-03 ES ES557188A patent/ES8800266A1/es not_active Expired
- 1986-11-03 ES ES557189A patent/ES8800267A1/es not_active Expired
-
1990
- 1990-10-17 IL IL96043A patent/IL96043A0/xx unknown
-
1991
- 1991-03-07 US US07/665,967 patent/US5212072A/en not_active Expired - Lifetime
-
1994
- 1994-10-04 JP JP6264452A patent/JPH07215999A/ja active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19805334A1 (de) * | 1998-02-11 | 1999-08-12 | Otogene Biotechnologische Fors | Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3688333T2 (de) | Antikörper gegen Polypeptide, die gegen Peptide oder Proteine mit mindestens teilweise bekannter Aminosäure oder kodierender Nukleotidsequenz komplementär sind und diesbezügliches Aufbauverfahren. | |
PT87138A (pt) | Process for the preparation of adn recombinant molecules codin g polypeptide adn segments and of antibody compositions relate d with human tissue factor | |
DK532284A (da) | Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser | |
ES2075196T3 (es) | Metodo para el uso y la sintesis de peptidos. | |
DE3855536D1 (de) | Rezeptoren für wachstumshormone | |
PL393286A1 (pl) | Rozpuszczalny receptor BR43x2 i sposoby jego zastosowania | |
LU91014I2 (fr) | Kogentate (Octocog alfa) dans toutes ses formes couvertes par le brevet de base | |
ATE177758T1 (de) | Synthetische peptide, antikörper dagegen und ihre verwendung | |
ATE50458T1 (de) | Bestimmung von fibrin mit fibrin-spezifischen antikoerpern. | |
ATE133993T1 (de) | Protein-antikrebsmittel | |
ES2109225T3 (es) | Anticuerpos, su produccion y uso. | |
KR890012669A (ko) | 심방 나트륨이뇨성 폴리펩티드를 인지하는 단일클론성 항체 | |
SE8502722D0 (sv) | Sett att bestemma vissa polypeptider samt medel for anvendning derfor | |
ATE317851T1 (de) | Polypeptide mit aminosäuresequenzen aus dem n- terminalen bereich von gp116 von cytomegalovirus und deren verwendung bei der diagnostik, prophylaxe und therapie | |
Roholt et al. | A light chain tyrosyl sequence in the antibody site of a rabbit anti-p-azobenzoate antibody | |
Carrel et al. | Studies on sheep anti-human IgG antibodies and their sub-units |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |